SOURCE: Given Imaging

November 16, 2007 08:30 ET

Given Imaging to Present at the NASDAQ TASE Israeli Investor Conference

YOQNEAM, ISRAEL--(Marketwire - November 16, 2007) - Given Imaging (NASDAQ: GIVN) today announced that Yuval Yanai, Chief Financial Officer, will present at the NASDAQ TASE Israeli Investor Conference taking place in New York City on Tuesday, November 27. Mr. Yanai is scheduled to present at 3:15pm ET.

To access a live webcast of this presentation, visit www.givenimaging.com and click on 'About Given Imaging.' The webcast will be available in the Investor Relations section. A replay will be available for two weeks at the above-referenced website.

About Given Imaging Ltd.

Given Imaging is redefining gastrointestinal diagnosis by developing, producing and marketing innovative, patient-friendly products for detecting gastrointestinal disorders. The company's technology platform is the PillCam® Platform, featuring the PillCam video capsule, a disposable, miniature video camera contained in a capsule, which is ingested by the patient, a sensor array, data recorder and RAPID® software. Given Imaging has a number of available capsules: the PillCam SB video capsule to visualize the entire small intestine which is currently marketed in the United States and in more than 60 other countries; the PillCam ESO video capsule to visualize the esophagus; the Agile™ patency capsule to determine the free passage of the PillCam capsule in the GI tract and the PillCam COLON video capsule to visualize the colon that has been cleared for marketing in the European Union, and is pending clearance with the United States Food and Drug Administration. More than 600,000 patients worldwide have benefited from the PillCam capsule endoscopy procedure. Given Imaging's headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel. It has operating subsidiary companies in the United States, Germany, France, Japan and Australia. For more information, visit http://www.givenimaging.com.

Contact Information